# C5orf34

## Overview
C5orf34 is a gene located on chromosome 5 that encodes the protein known as chromosome 5 open reading frame 34. This protein is involved in various cellular processes, although its specific functions remain to be fully elucidated. Emerging research suggests that C5orf34 may play a role in the regulation of the immune microenvironment and has potential implications in cancer biology. The gene's expression and methylation patterns have been associated with prognostic outcomes in several cancer types, indicating its potential as a biomarker for disease progression and patient survival (Li2023Integration). Further studies are needed to clarify the molecular mechanisms by which C5orf34 influences cancer pathogenesis and to explore its utility in clinical applications (Li2023Integration).

## Clinical Significance
C5orf34 has been implicated in various human malignancies, with its expression levels significantly altered in several cancer types. Increased expression of C5orf34 is associated with poor prognosis in cancers such as cholangiocarcinoma, liver hepatocellular carcinoma, and uterine corpus endometrial carcinoma, where it correlates with worse overall survival, disease-specific survival, and progression-free intervals (Li2023Integration). The gene is also up-regulated in gynecologic cancers and is linked to clinical features, suggesting its role in the immune microenvironment and potential as a prognostic biomarker (Li2023Integration).

C5orf34 expression is generally higher in cancer tissues compared to normal tissues, although it is less expressed in certain cancers like leukemia, prostate cancer, and breast cancer (Li2023Integration). The gene's methylation levels are typically lower in cancer tissues, with higher methylation correlating with better prognosis in some cancers, such as cholangiocarcinoma and glioblastoma (Li2023Integration).

Mutations and copy number variations in C5orf34 are linked to different prognostic outcomes. For instance, amplification of C5orf34 in adrenocortical carcinoma is associated with better disease-free intervals, while in thyroid carcinoma, it correlates with worse prognosis (Li2023Integration). The gene's expression is also linked to tumor mutation burden and microsatellite instability, although these correlations are not strong enough to predict immune-checkpoint blockade responses (Li2023Integration).


## References


[1. (Li2023Integration) Yilin Li, Yong Zhang, Dan Sun, Xiaofeng Zhang, Shangqin Long, Jiuxiang Feng, and Zhongmin Wang. Integration of genomics and transcriptomics highlights the crucial role of chromosome 5 open reading frame 34 in various human malignancies. Aging, 15(23):14384â€“14410, December 2023. URL: http://dx.doi.org/10.18632/aging.205310, doi:10.18632/aging.205310. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.18632/aging.205310)